InterMune: Clinical Trials

1 trial sponsored by InterMune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow InterMune: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients
Interferon Gamma-1b, Rituximab - Non-Hodgkin's Lymphoma
Phase 1 / Phase 2TerminatedInterMune242003-03-012007-11-01

Conditions studied

Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)

Interventions

Rituximab (1)  ·  interferon gamma-1b (1)

Countries

United States (1)

Top investigators

Williamson Bradford, MD (1)